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Background: The regeneration of articular hyaline cartilage remains an elusive goal despite years of research.
Recently, an aragonite-hyaluronate (Ar-HA) biphasic scaffold has been described capable of cartilage regeneration
over a 6-month follow-up period. This study was conducted in order to assess the fate of the regenerated
osteochondral tissue in a 12-month-long validated caprine model.
Hypothesis/purpose: The hypothesis was that the implantation of the Ar-HA implant leads to tissue regeneration
and maturation.
Study design: A two-arm caprine model of a critical osteochondral defect compares the fate of acute osteochondral
defects (group A) to Ar-HA implanted defects (group B).
Methods: Critical 6 mm in diameter and 10-mm in depth osteochondral defects were created in the load-bearing
medial femoral condyle of 20 mature goats and randomized into two groups. In group A (n = 6), a blood clot
spontaneously filled the defect; in group B (n = 14), a single Ar-HA implant reconstructed the defect. The animals
were sacrificed after either 6 or 12 months. Parameters assessed included clinical evaluation, x-rays, micro-CT,
ultrasound and histology at both time points, and specimen high-field magnetic resonance imaging with T2
mapping at the 12-month time point.
Results: In most group A animals, the defects were not reconstructed (1/3 at 6 months, and 0/3 at 12 months).
Defects in group B were mostly reconstructed (5/7 at 6 months and 6/7 at 12 months). Group A defects were
either empty or contained fibrous repair tissue; while group B filling was compatible with hyaline cartilage and
normal bone.
Conclusion: Ar-HA scaffolds implanted in critical osteochondral defects result in hyaline cartilage formation and
subchondral bone regeneration. The results improved at the 12-month time point compared to the 6-month
time point, indicating a continuous maturation process without deterioration of the repair tissue.
Clinical relevance: Osteochondral defects are common in humans; the results of the current study suggest that
an acellular Ar-HA scaffold might induce cartilage and subchondral bone regeneration.
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Numerous surgical approaches have been proposed
over the years to treat chondral or osteochondral le-
sions [1, 2], but native hyaline cartilage regeneration
has not been achieved by any available treatment. In
general, two approaches to treat articular cartilage are
feasible: exogenous-cell-based techniques or locally re-
cruited stem-cell-based techniques. Sophisticated cell-
based technologies are feasible but difficult to justify in
this economy-conscious age [3]. Regenerative scaffold-
based procedures are emerging as a promising thera-
peutic option for the treatment of chondral lesions.
Several one-step scaffold-based strategies are proposed
to simplify the procedure and reduce costs [4, 5]. The
properties of the graft can be specifically tailored to
provide structural, biological and biomechanical cues
that are necessary for a reproducible and durable re-
pair. The optimal scaffold should allow bone repair in
the subchondral area (a goal quite difficult to achieve
as the bone tends to be a mixture of compact and
woven bone [6]) and migration of mesenchymal stem
cells and chondrocytes into the superficial cartilaginous
layers, with new cartilage formation at the articular sur-
face [6]. The regenerated cartilage should integrate into
both the basal tissue as well as the surrounding periph-
eral cartilage [7, 8].
A recent study showed the potential of a newly devel-
oped aragonite-hyaluronate (Ar-HA) scaffold (Agili-
CTM, CartiHeal (2009) Ltd., Israel) as an ideal composite
material with biological and mechanical properties for
chondral and osteochondral regeneration [9]. Safety
and cartilage regeneration potential were evaluated in a
goat model with 6-month follow-up. Kon et al. [9] de-
scribed an optimal coralline aragonite scaffold configur-
ation—with a drilled channel pattern impregnated with
hyaluronic acid (HA) at the articular surface. The car-
tilaginous repair tissue presented a smooth contour
and was well integrated into the adjacent native cartil-
age, with morphological evidence of hyaline cartilage,
confirmed by the presence of proteoglycans and colla-
gen type II and the absence of collagen type I. Initial
human clinical experience with the Ar-HA scaffold was
obtained when implanted in an Outerbridge grade IV
medial condylar defect measuring about 2 cm2. Six
months following the procedure, the patient returned
to sport activities and a 24-month MRI confirmed ar-
ticular surface restoration [10].
A spectre haunting cartilage repair therapies is the
long-term outcome. The purpose of this study was to
confirm the durability of the regenerated hyaline cartil-
age in a caprine model over a 1-year period. The study
hypothesis was that the modified Ar-HA based implant
leads to the regeneration of long-term durable hyaline
cartilage.Materials and methods
Implanted device
The implanted device has been previously described
both in animal studies and in human implantation
[9, 10]. It is an Ar-HA biphasic implant (Fig. 1). Its
unique nano-rough structure and the interconnecting
porosity stimulate cell adhesion and proliferation as well
as matrix production (Fig. 2).Experimental model
One of the recommended experimental models for
osteochondral defect evaluation is a goat model [11].
Goats and sheep are readily available from commercial
and agricultural suppliers as 2-year-old or older animals
that are skeletally mature. According to ASTM F2451
largely due to their stifle size, cartilaginous thickness,
availability, and ease of handling, goats represent a favor-
able animal model for cartilage repair studies [12]. The
lesion size is important, and critical-size defects should
be used for pivotal studies. In such pre-clinical study,
the choice of comparator is important. A 7-mm diam-
eter defect has been shown to lead to osteoarthritic
changes in an ovine model [13]. Thus, a similar defect
(slightly smaller due to slightly smaller caprine size) was
chosen as a critical defect in our study based on previ-
ous studies demonstrating lack of spontaneous repair at
this defect diameter[14, 9, 13]. The overall study design
is delineated in Fig. 3. As the model of blood-clot-filled
defect is well known for its lack of healing ability in the
goat [15, 13], a 1:2.3 randomization scheme was used.Rationale for choice of control group
The current study aimed at assessing the repair augmen-
tation of acute osteochondral defects with an acellular
scaffold as compared with blood clot. Results with
chronic defects have been shown to be similar previously
with clear superiority of osteochondral scaffolds filling
the defects as compared with spontaneous healing [14].
Clots are known to allow some tissue regeneration; how-
ever, regarding the goat model, it is well known that full-
thickness osteochondral defects, measuring 6 mm in
both diameter and depth, that are created in the medial
femoral condyle of the knee joint of adult Spanish goats
do not heal [15]. Clot-filled empty defect seems to be an
appropriate control group choice as it simulates the oc-
currence following trauma in humans and the repair re-
action generated. It is well known that even joints that
appear to self-heal 6 months after osteochondral defect
creation, later undergo degeneration at 12 months post-
defect creation [13, 16]. Due to these observations and
as there is no gold-standard treatment of osteochondral
defects in current clinical practice, an empty osteochon-
dral defect was chosen as a comparator in the current
Fig. 1 Micrograph of the Ar-HA scaffold (a), the biphasic nature is obvious with a thin hyaluronate covered cartilage phase, overlying a thick bone
phase. Close-up of the bone phase demonstrates the typical corallites structure with radial septo-costae (b). The coral material is nano-rough
making it a stem cell attractor (c)
Fig. 2 The Ar-HA scaffold has an interconnecting porosity, with an average of 100-μm pore size (a). The coral material supports human stem cell
adhesion and mitosis (arrow) as soon as 24 h after seeding (b). A larger magnification demonstrates that 24 h after seeding the human stem cells
are well attached to the nano-rough surface and deposit a substance on the side opposite to the scaffold (presumably osteoid, arrow) (c). Seven
days after seeding, tissue is covering the scaffold and partially filling the pores (d) (environmental scanning electron microscopy of human
embryonic palatal mesenchyme (HEPM) cells, seeded at about 15,000 cells per well, were seeded in a 48-well plate on scaffolds. Cells were grown
in HEPM growth medium for up to 7 days)
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Fig. 3 The study included 20 animals in whose right medial femoral condyle, a critical size defect was created. The animals were randomized at
1:2.3 ratio into two groups: group A—the defect was created and blood was allowed to clot in it; this group served as a control group, group
B—experimental group—Ar-HA-implanted group
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draft guidance [12, 17].Animals
Twenty skeletally mature, female, Saanen goats, 48 ± 6
kg average weight (41–61 kg), non-pregnant and non-
lactating, were acquired from an authorized farm and
quarantined for at least 45 days before entering the trial.
The goats used in this study were screened for caprine
encephalitis prior to inclusion in the cohort group as it
is a common cause of adult goat arthritis.
Six animals served as a control group (group A), with
an empty defect 6 mm in diameter and 10-mm depth
that spontaneously filled with blood clot within a few
minutes (Fig. 3) created in the medial load bearing area
of the MFC of the right hind-limb. Fourteen animals
were implanted with a single implant (group B), inserted
into an osteochondral defect created in the middle partof the load-bearing medial femoral condyle (MFC) of the
right hind-limb (Fig. 1b).
Animal care and surgery were approved by the Ethical
Committee of the Experimental Center and performed
under the Animal Welfare Law and according to applic-
able ISO 10993 Standards. The study was conducted in
accordance with the following standards:
ASTM F2451-05 Standard Guide for in vivo Assess-
ment of Implantable Devices Intended to Repair or Re-
generate Articular Cartilage.
Preclinical Studies for Cartilage Repair: Recommenda-
tion from the International Cartilage Repair Society; ICRS
Recommendation Papers, Cartilage 2(2) 137–152, 2011.
International Cartilage Repair Society (ICRS) Recom-
mended Guidelines for Histological Endpoints for Cartil-
age Repair Studies in Animal Models and Clinical Trials,
Cartilage 2 (2) 153–172, 2011.
Three group A animals and seven group B animals were
sacrificed at each timepoint. The study was approved by
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(Zeriffin, Israel).Surgical procedure
Surgery was conducted under general anesthesia via a
mini-arthrotomy approach. A minimal exposure of the
implantation site was made using retractors with the
limb placed at maximal flexion, allowing joint access
without patellar dislocation. A specifically developed sur-
gical tool set, (Agili-KitTM, CartiHeal (2009) Ltd., Israel)
was used for the implantation. After defect creation an
implant was inserted. The implant reached its final pos-
ition in a press-fit manner, slightly below the articular
surface. The knee capsule and skin were then sutured.
Intramuscular antibiotics (Cephalexin, 1 g ×3 for 24 h)
and oral analgesics (Dipyrone, P.O. 1 g per day for 24 h)
were administrated postoperatively. Following the surgi-
cal procedure, the goats were placed in protected stalls
with limited space for movement (2 × 2 m) with imme-
diate load-bearing and ad libitum food and water supply.
After 10 days the goats were transferred to a study spe-
cific research pen allowing unhindered ambulation. The
goats’ welfare was monitored by a veterinarian on a rou-
tine basis throughout the study. Ten animals were evalu-
ated 6 months post implantation and the other ten
animals were evaluated 12 months post implantation.
Animals were euthanized by pharmacological premedica-
tion (ketamine (3 mg/kg), xylazine (0.1 mg/kg) and an in-
jection of 50 cc KCl (150 mg/ml). Prior to euthanasia,
clinical evaluation, blood tests and ultrasonography im-
aging were performed. After sacrifice, macroscopic and
histological analysis as well as x-rays, micro-CT, and MRI
of the explanted specimens were performed in a blinded
manner.Repair tissue evaluation
Ultrasound
Ultrasound imaging of the operated joint was performed
prior to sacrifice, as the procedure requires physical sub-
duing of the tested animal and to prevent the possible
interference effect from this physical manipulation with
other assessments the examination was performed 5
months post procedure, during the in-vivo phase, for the
entire animal group (about 3 weeks prior to sacrifice of
some of the animals). An additional ultrasound was per-
formed 11 months post procedure (again in order to allow
enough time to elapse prior to sacrifice) for the 12 month
group. The ultrasound transducer used was GE Trans-
ducer 11L Logiq_e® 12 MHz. Evaluation of the ultrasound
results according to gross appearance scaling system
modified from Fortier et. al [18] and ICRS macroscopic
cartilage assessment score [19] was performed in a blinded
manner by an independent veterinarian radiologist.X-rays
X-rays were performed on the right and left hind-limbs
of the goats, i.e., the operated and non-operated knees
for comparison. The radiographic imaging was con-
ducted after joint harvesting and before macroscopic
evaluations, using a GE OEC-9800 C-arm system. The
radiographs were evaluated in a blinded manner for the
following parameters: bone cysts, osteophytes, subchon-
dral sclerosis, joint space narrowing and other arthritic
changes.
Macroscopic evaluation
At both time points (6 and 12 month’s follow-up),
macroscopic evaluation was conducted in a blinded
manner by a team of human and veterinary orthopedic
surgeons. The evaluations performed were: ICRS
macroscopic cartilage assessment scoring [19] and
gross appearance scaling system (modified from Fortier
et al.) [18]. The opposing articular surface was also
evaluated.
Micro-CT
Micro CT was performed at the 12-month time point
on the harvested condyles, using a TomoScope® Synergy
stand-alone in-vivo micro-CT scanner (scan time 90 s,
one gantry rotation, radiation dose 322 mGy/cm, tube
voltage 65 kV, current 1 mAmp). This dedicated small
animal CT system has an 80 μm resolution. Bone density
was calculated as occupied bone trabeculae area divided
by total region of interest area. Structural density was
calculated at both the repair site and the periphery. Each
value represents averaging of three randomly chosen
×20 magnification fields. The density at the periphery
was assumed to represent bone affected indirectly by the
defect creation and somewhat similar to normal bone.
Thus, subtraction of repair site structural density from
the peripheral bone density allows evaluation of the pro-
cedure specific bone formation.
MRI imaging and data analysis
At the 12-month time point, the specimens were
scanned in a 7T MRI system (Bruker, Germany). A T2
protocol was performed (T2-MSME sequence; TR =
1844.32 ms; ten different TEs: 8; 16; 24; 32; 40; 48; 56;
64; 72; 80 ms; number of averages: 3; scan time: 11 min
48 s 218 ms; matrix: 160 × 160 pixel; spatial resolution:
0.15625 mm/pixel × 0.15625 mm/pixel; slice thickness:
0.8 mm). The images produced allowed assessment of
the cartilage (appearing as a high signal tissue due to its
high water content, and the subchondral bone that ap-
pears as a very low signal tissue). With quantitative T2
mapping, the collagen structure and water content can be
appreciated [20]. A quantitative T2 map was generated for
each sample from the T2 weighted images using in-house
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USA). T2 relaxation time non-linear fit in each voxel was
calculated according to the equation S(t) = S(0)exp(−t/
T2)/2/. The T2 images were presented in a color coded
map representing the T2 values. Regions of interest (ROIs)
were collected from two areas: newly formed cartilage at
the implantation site and peripheral cartilage proximal to
the implantation site.
Additionally, cartilage thickness was measured using
ImageJ 1.45S software by NIH USA (Wayne Rasband),
by a “straight line” measurement tool at four random
points in each defect and in the peripheral area of the
scan. Specimens were scored blinded according to the
New 3-D MOCART score [21] by an independent veter-
inarian radiologist (modified to exclude the effusion
parameter as isolated specimens were evaluated and ef-
fusion could not be evaluated).
Histology and immunohistochemistry
Gross specimens were sent to an independent labora-
tory, NAMSA—BIOMATECH (Zl De L’Islon 115 Rue
Pasteur, France) for histological preparations and evalua-
tions at both sacrifice time points. The specimens, em-
bedded in paraffin blocks, were longitudinally cut (5 μm
thickness +/−0.5 μm) using a microtome (MICROM®,
France). For each specimen, six central serial sections
were prepared. Safranin hematoxylin eosin (SHE) stain-
ing was used for analysis of the inflammatory reaction;
Masson’s trichrome (MT) for general morphology as-
sessment including analysis of the fibrous tissue pattern;
Safranin-O/Fast Green (SOFG) histochemical staining
for the proteoglycan content (the SOFG staining was
simultaneously carried out in the same bath to avoid
stain variability); Feulgen and Rossenbeck histochemical
staining for quantitative analysis of the cartilage cellular-
ity. Other two sections were used for the immunohisto-
chemistry (IHC) determination of collagen type I (Coll I)
(fibrous tissue marker, polyclonal antibody obtained
from Abcam plc., 330 Cambridge Science Park, Cam-
bridge, UK, Ref. ab90395 at dilution 1:100) and collagen
type II (Coll II) (hyaline cartilage marker, polyclonal
antibody obtained from Abcam, Ref. ab34712 at dilution
1:800). Slides were then incubated with a biotylinated
link (Dako France S.A.S. Parc Technopolis, 3 Avenue du
Canada, 91978 Les Ulis Cedex; Kit reference K5001) for
15 min at room temperature. All slides were visualized
with 3,3-diaminobenzidine chromogen + (DAKO; Kit
reference K5001) and a Mayer hematoxylin counterstain.
Semi-quantitative evaluation of the local tissue effects
was performed to assess the inflammatory reaction
(polymorphonuclear cells, lymphocytes, plasma cells,
macrophages and giant cells/osteoclasts), fibrin, necrosis,
osteolysis and neovessels using a 0–4 grading scale. The
performance parameters were graded according to acombination of the ICRS II grading scale and the
O’Driscoll et al. grading scale [22] (see Table 1);
the score was described as a total performance score
(TPS) ranging from 0–36 points according to the fol-
lowing parameters: nature of predominant tissue (tissue
morphology and Safranin-O/Fast Green staining of the
matrix), structural characteristics (surface regularity,
structural integrity, thickness, bonding to the adja-
cent cartilage, basal integration, tidemark, subchondral
bone abnormalities/marrow fibrosis, cancellous bone
regeneration and abnormal calcification/ossification),
freedom from cellular changes of degeneration (hypo-
cellularity and chondrocytes clustering), freedom from
degenerative changes in adjacent cartilage and overall
assessment. Slides were evaluated under polarized light
for the determination of the collagen organization. The
immune-labeled slides were qualitatively evaluated for
the presence of collagen type I and type II. Alickert-
type 5 point semi-quantitative score ranging from 0 to
4 was used to score overall assessment (OA).
The histological preparation and evaluation was con-
ducted in compliance with the OCDE Good Laboratory
Practice, ENV/MC/CHEM (98) 17, section II § 2.2 and
9.2, with the European Good Laboratory Practice regula-
tions, 2004/10/EC Directive, section II § 2.2 and 9.2 and
with the United States Food and Drug Administration
Good Laboratory Practice regulations, 21 CFR 58 sub-
parts B 35 (b) and J 185 (a). All evaluations were per-
formed in a blinded fashion by a veterinary pathologist
(NAMSA).
Statistical method
Statistical analyses were performed using Analyse-It
statistical Microsoft 2010 Excel add-in (version 3.70.1).
A p-value of 0.05 or less was considered statistically sig-
nificant. Continuous variables with normal distribution
were compared using the Student’s t-test or Welch
ANOVA. Non-parametric variables were analyzed using
the Wilcoxon–Mann–Whitney test or the Kruskal-
Wallis test as appropriate.
Results
All goats recovered well and quickly returned to normal
walking ability within 2 days of surgery. In the study ani-
mals, there was no evidence of any movement restriction
or joint locking in any of the cases. One (SAE) serious
adverse event occurred during the study; a group A ani-
mal suffered from cysticercosis (considered to be unre-
lated to the study). This led to death 5 days before
scheduled sacrifice (the joint was retrieved for analysis
according to the protocol). Minor adverse events oc-
curred similarly (weight loss, high temperature, sneez-
ing) in both groups. Group A animals gained 5 ± 15 %
of total body weight while group B animals gained an
Table 1 Combined cartilage and ne repair score evaluation (from ICRS II-2010 and O’Dri oll et al.)
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Table 3 ICRS US score
ICRS US evaluation Min = 0,
max = 12
6 months* 12 months**
Ar-HA-implanted group 10.07 ± 1.63 (n = 14) 11.85 ± 0.34 (n = 7)
Control group 2.66 ± 3.14 (n = 6) 5.66 ± 3.39 (n = 3)
*Wilcoxon–Mann–Whitney test, w-statistic 25, p < 0.001
**Wilcoxon–Mann–Whitney test, w-statistic 6, p < 0.002
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test, t-statistic = −.091, difference not significant [n.s.]).
Ultrasound
The gross appearance scaling system score and ICRS US
score were significantly superior in group B at both time
points, as detailed in Tables 2 and 3. While ultrasound is
not commonly used in cartilage repair studies, it has
been shown to allow assessment of cartilage thickness in
the human knee and has shown a close correlation with
symptoms [23].
Macroscopic evaluation
The ICRS macroscopic cartilage assessment score was
higher for group B compared to group A at both time-
points (Fig. 4, n.s. difference at 6 months, and statistically
significant at 12 months Wilcoxon–Mann–Whitney test,
w-statistic 6, p < 0.02; Table 4). The Fortier’s gross appear-
ance scaling system was significantly superior for group
B at both time points (at 6 months, Wilcoxon–Mann–
Whitney test, w-statistic 29, p < 0.004; at 12 months
Wilcoxon–Mann–Whitney test, w-statistic 6, p < 0.02;
Table 5).
No adverse reaction or fibrillation was noted at the op-
posing articular surface in either group.
Micro-CT
Bone structural changes and anomalies, including cyst
formation, were seen in group A while in group B ani-
mals, the bone structure was similar to normal bone.
At the 6-month time point, group B animals had
structural density at the subchondral area of 56 ± 4 %
and at the 12-month time point of 45 ± 3 %, which was
similar to the peripheral area bone density (45 ± 2 %).
Scaffold residuals, yet not fully degraded, explain the
higher bone density at the 6-month time point versus
the 12-month time point in group B. In group A, lower
bone density values were measured at both 6 months
(35 ± 3 %) and at the 12-month time point (34 ± 4 %).
Due to the limited number of specimens, a statistical
analysis was performed of the pooled data from both
time points. The intergroup difference in structural
density was found to be significant (ANOVA, F-statistic
4.94, p < 0.04).Table 2 Gross appearance scaling system
Fortier gross appearance
scaling system
6 months* 12 months**
Min = 0, max = 15
Ar-HA-implanted group 9.71 ± 3.01 (n = 14) 13.71 ± 0.88 (n = 7)
Control group 2.66 ± 3.59 (n = 6) 5.33 ± 3.29 (n = 3)
*Wilcoxon–Mann–Whitney test, w-statistic 29, p < 0.004
**Wilcoxon–Mann–Whitney test, w-statistic 6, p < 0.002MRI imaging
Cartilage thickness-defect fill:
Six out of the 7 group B animals had cartilage which
was similar in thickness to the surrounding cartilage. In
one animal, regenerated cartilage thickness was thinner
than the surrounding cartilage. By contrast, in all of the
group A animals, tissue coverage over the defect area
was thinner compared to the surrounding native cartil-
age (Fig. 4).
New MOCART scoring:
The 3D New MOCART evaluation showed a signifi-
cant intergroup difference in favor of group B (Student’s
t-test, p < 0.05) for the following parameters: defect fill,
cartilage interface, bone interface, surface, structure,
chondral intralesional osteophytes, bone marrow edema,
and subchondral bone. The overall New MOCART score
(scored as a sum of all parameters assessed) was also
found to be significantly superior in group B animals (32 ±
1 versus 17 ± 1, p < 0.001; Table 6).
At the 12-month time point, significantly lower (Stu-
dent’s t-test, p < 0.001) T2 values were found in group B
in the regenerated tissue overlying the defect (22.3 ± 9.6)
versus group A (4.93 ± 9.9), which implies better quality
of cartilage formation. Twelve months following creation
of an osteochondral defect in the group A animals, there
was also evidence of surrounding cartilage deterioration
with significantly higher T2 values in group A animals
(42.9 ± 29.9) as compared to the T2 values found at the
peripheral cartilage of group B animals (27.0 ± 9.3, Stu-
dent’s t-test, p < 0.05).
Histology
Summary
After 6 and 12 months, no significant local inflammation
was observed in both groups (see Table 7 and Fig. 5). At
6 months, most group B specimens (5/7) were associated
with a high level of healing performance, with formation
of young articular hyaline cartilage and advanced signs
of subchondral bone regeneration, resulting in an aver-
age total performance score (TPS) of 31.0 ± 4.5 in group
B as compared to group A with a TPS of 16.3 ± 14.5
(ANOVA test, F-value 6.68, p < 0.035). The large vari-
ability of the group A repair reaction is related to the
fact that in two animals, the defects were not healed but
in one animal, the defect healed spontaneously with ir-
regular subchondral bone.
Fig. 4 Results at 12 months post implantation of the median animal from group A (left column) and the median animal from group B (right
column) using several evaluation modalities: a Macroscopic appearance of group A defect; a crater is visible at the site of the osteochondral
defect (arrow). b Opposing articular surface of the tibia of same animal as (a) demonstrates a large area of tibial cartilage damage (dashed line). c
Group B animal condyle appears to be perfectly covered with cartilage. d Opposing tibial cartilage in a group B animal is intact. e T2 mapping of
a group A animal demonstrates abnormal signal indicating cartilage degeneration both overlying the defect (dashed box) and in the surrounding
tissue. f T2 MRI scan demonstrates a cyst in the subchondral bone and abnormal dark signal in the superficial repair tissue supporting a fibrous
content of the tissue. g A CT scan demonstrates some bone formation within the defect surrounding a large cyst and a lack of subchondral bone
plate reconstruction. h Group B median animal demonstrates normal T2 mapping both within the tissue overlying the implant and in the
periphery. Note the zonation of the repair tissue (blue-hued tissue overlying a purplish zone that is attached to the bone) indicating a likely
hyaline cartilage nature of the repair tissue. i T2 scan of a group B animal indicates excellent subchondral bone regeneration with superficial
tissue formation whose signal is typical of hyaline cartilage. j On CT scan, the bone tissue is fully reconstructed and the subchondral bone plate is
similar in thickness and contour to its surroundings
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were significantly higher than group A’s TPS (ANOVA
test, F-value 9.09, p < 0.02) with 6/7 healed specimens
with hyaline cartilage tissue and subchondral bone and
the seventh specimen healed with almost complete hya-
line cartilage tissue and high TPS (33.0 ± 5.9). In con-
trast, none of the group A specimens were fully repaired
and the TPS was low (18.0 ± 7.2). Comparing the group
A TPS score at both time points demonstrate that the
healing was similar over time (ANOVA Dunnet multipleTable 4 ICRS macroscopic cartilage assessment score
ICRS macroscopic evaluation 6 months 12 months
Min = 0, max = 12
Ar-HA-implanted group 9.57 ± 1.39 (n = 7) 11.42 ± 0.72 (n = 7)
Control group 6.33 ± 4.49 (n = 3) 7.33 ± 0.47 (n = 3)comparisons against control, mean difference 1.7, n.s.). Be-
tween 6 and 12 months, the group B’s TPS further im-
proved, albeit the difference was not statistically significant.
The overall assessment at 6 months was significantly
lower (2 ± 1.6) for the group A versus the group B animals
(3.43 ± 0.9, Kruskal-Wallis test, H-statistic 9.85, p < 0.02).
In order to evaluate the collagen type II content of the
repair tissue, the data were pooled for the 6-months and
12-month group due to the few animals in the controlTable 5 Fortier’s gross appearance scaling system
Fortier gross appearance
scaling system
6 months 12 months
Min = 0, max = 15
Ar-HA-implanted group 12.71 ± 2.60 (n = 7) 13.71 ± 1.03 (n = 7)
Control group 5.66 ± 2.49 (n = 3) 9.33 ± 1.24 (n = 3)
Table 6 MOCART score of specimens removed at animal
sacrifice 12 months after operation
New 3D-MOCART
score parameter
HA-AR group Control group
Mean ± SD Mean ± SD
Defect fill 4 ± 0.1 2 ± 0.8
Cartilage interface 4 ± 0.1 2 ± 0.8
Bone interface 4 ± 0.1 3 ± 0.8
Surface 3.9 ± 0.3 2.3 ± 0.5
Structure 1.9 ± 0.3 1 ± 0.1
Signal intensity 2.4 ± 0.5 1 ± 0.1
Subchondral lamina 1.9 ± 0.3 1.3 ± 0.5
Chondral osteophytes 2.6 ± 0.7 1 ± 0.1
Bone marrow edema 4 ± 0.1 2.7 ± 0.9
Subchondral bone 3.4 ± 0.9 1.7 ± 0.5
Overall score 32 ± 1 17 ± 1
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staining (median 2.5, range 0–3) versus group B (median
3, range 2–3, Student’s t-test, t-statistic −2.7, p < 0.015).
Safranin-O staining, indicating proteoglycan content of
the repair tissue was higher in group B (2.6 ± 0.6) versus
group A (2.2 ± 1, Student’s t-test, t-statistic −1.31, n.s.;
Table 8).
6-month time period
Empty defect control group (n = 3)
Two out of three specimens were not healed, and the
defects were filled with fibrous tissue and one site healed
spontaneously at the cartilage level, with thin layer of
hyaline cartilage, but with formation of an irregular sub-
chondral bone with a large bone cavity.
Ar-HA test group (n = 7)
Five out of seven sites were healed with formation of
hyaline cartilage. In these animals, the formation of hya-
line cartilage was confirmed by marked presence of pro-
teoglycans, a marked grade of collagen type II, and
absence or traces of collagen type I within this cartil-









Agili-C Mean 0.0 0.6 0.0
SD 0.0 0.5 0.0
Empty
defect control
Mean 0.0 0.0 0.0
SD 0.0 0.0 0.0
12
months
Agili-C Mean 0.0 0.3 0.0
SD 0.0 0.7 0.0
Empty
defect control
Mean 0.0 0.3 0.0
SD 0.0 0.5 0.0
Grading scale: 0: absence, 1: slight, 2: moderate, 3: marked, 4: severe SD: standard dsmooth. The regenerated cartilage was well integrated
into the adjacent native cartilage and basal tissues. A
newly formed tidemark was observed between the cartil-
age and the bone tissues. The subchondral plate was
largely reconstructed. The underlying cancellous bone
was moderately reconstructed.
Two out of seven sites were healed with generation of
a fibrocartilage tissue. One of these animals showed de-
layed subchondral bone reconstruction.
12-month time period
Group A (n = 3)
None of the sites had fully healed. Only one of the
sites showed advanced signs of cartilage healing, but the
subchondral bone formation was not achieved.
There were none to mild signs of inflammation with
infiltration of macrophages, giant cells, and fibrin observed
in the repair tissue. The neovascularization was of slight
grade. One specimen showed incomplete signs of healing
with presence of intra-cartilage clefts, remaining active fi-
broblasts and fibrous tissue, hemorrhage, and delayed sub-
chondral bone plate formation. One specimen displayed
cartilaginous repair tissue with morphological evidence of
hyaline cartilage as confirmed by the presence of proteo-
glycans and collagen type II and absence of collagen type I
within this cartilaginous tissue. However, this specimen
was not considered as fully healed due to a noticeable de-
formation of the subchondral plate indicating incomplete
bone and cartilage repair. The third specimen showed no
cartilage formation with a small area of denuded bone.
Group B (n = 7)
In group B, six out of seven sites displayed formation
of a hyaline cartilage repair tissue. The remaining site
was almost fully healed and showed hyaline cartilage for-
mation in most parts (Fig. 2).
Residual signs of local inflammation were observed in
only two out of seven sites. No significant signs of neo-
vascularization were observed in any of the specimens.
Six out of seven specimens exhibited cartilaginous repair
tissue with morphological evidence of hyaline cartilage.atory reaction (results)
Macrophages Giant cells/
osteoclasts
Fibrin Necrosis Osteolysis Neovessels
1.3 1.0 0.9 0.0 0.0 1.6
0.5 0.0 0.8 0.0 0.0 0.5
0.3 1.0 1.0 0.0 0.0 1.7
0.5 0.0 0.8 0.0 0.0 0.5
0.7 1.1 0.1 0.0 0.3 0.0
0.9 0.3 0.3 0.0 0.7 0.0
0.7 1.3 0.3 0.0 0.0 1.0
0.5 0.5 0.5 0.0 0.0 0.8
eviation
Fig. 5 Histological evaluation of osteochondral defects 12 months postop (original magnification of (a–h) ×12, white dashed box is the
osteochondral defect outline). a A proteoglycan-specific dye stains the cartilage layer in a group A animal. The osteochondral defect is still not
reconstructed with eburnated bone at the joint surface. Note cartilage disruption, cleft formation, cartilage matrix loss. disrupted subchondral
bone plate, and irregular bone trabeculae (Safranin-O stain, Fast Green counterstain). b A group B animal showing normal cartilage. c A bone cyst
is seen in a group A animal (arrowhead), with massive thickening of the subchondral bone plate (Masson Trichrome stain). d A group B animal
demonstrates perfect repair of the subchondral bone underlying the regenerated cartilage (arrowhead) (Masson Trichrome stain). e Collagen type
II staining reveals lack of collagen type II in some of the arthritic tissue overlying the osteochondral defect with some staining in the bone cyst
indicating heterotopic cartilage formation in a group A animal (anti-collagen type I antibody). f Collagen type II stain is uniform in the newly
created cartilage in a group B animal; there is no collagen type II staining in the regenerated subchondral bone (anti-collagen type II antibody). g
Collagen type I stain is uniform in the bone, but there are areas within the articular cartilage that stain positively as well in a group A animal
(anti-collagen type I antibody). h Uniform collagen type I stain in a group B animal (anti-collagen type I antibody). i Disordered repair collagen
fibrils are evident in this polarized light microscopy image of a group A animal and lack of repair tissue zonation (original magnification of this and j
was ×40). (j) Well-ordered mature collagen fibrils are evident within the subchondral bone in a group B animal. The cartilage layer demonstrates a clear
zonation phenomenon
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presence of proteoglycans and collagen type II and ab-
sence of collagen type I within the cartilaginous tissue.
The cartilaginous repair tissue was well integrated into
the adjacent native cartilage and basal tissues in all sites.A reconstructed subchondral bone plate with a clear
tidemark was observed in all specimens, at the exception
of one specimen that showed a small localized thin
fibrocartilage layer, on the boundary of one side of the
implantation site. In that last specimen, most part of the
Table 8 Combined cartilage and bone rep ir score results (from ICRS II-2010 and O’Dris ll et al.)
Time
period



















Agili-C Mean 3.4 2.4 2.4 1.6 1.9 2.0 4.0 2.6 2.6
SD 0.9 0.7 0.5 0.5 0.3 0.0 0.0 0.5 1.0
Empty defect
control
Mean 2.0 2.0 1.7 1.0 0.7 1.0 1.3 1.0 0.0
SD 1.6 0.8 1.2 0.8 0.5 0.8 1.9 1.4 0.0
12
months
Agili-C Mean 3.7 2.9 2.0 1.7 1.6 2.0 4.0 2.9 2.6
SD 0.7 0.3 0.8 0.5 0.7 0.0 0.0 0.3 1.0
Empty defect
control
Mean 1.7 2.3 0.3 0.7 1.0 1.7 2.3 1.7 0.0





















































assessmentCancellous bone regeneration Abnormal calcification/ossification
(cartilage tissue)
Hypocellularity Chondrocyte clustering
6 months 2.3 0.0 2.9 0.4 2.6 31.0 3.0 0.4 3.4
0.7 0.0 0.3 0.5 0.5 4.1 0.0 0.7 0.9
1.3 0.0 2.0 0.7 1.7 16.3 2.0 1.2 2.0
0.5 0.0 1.4 0.5 1.2 11.8 1.3 1.0 1.6
12 months 3.6 0.0 2.4 1.0 2.7 33.0 2.9 0.1 3.9
0.7 0.0 0.7 0.0 0.7 5.5 0.3 0.3 0.3
1.3 0.3 2.0 1.3 1.3 18.0 1.7 0.3 1.0
0.5 0.5 0.8 0.5 1.2 8.3 1.2 0.5 0.8
SD standard deviation
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cancellous bone was reconstructed in all specimens in a
marked process of osteotransduction. In two specimens out
of seven, a bone cavity, filled with adipocyte bone marrow,
was observed deep in the bone phase, between the bottom
of the implant and the floor of the implantation site.
Discussion
Current cartilage repair therapies are notorious for their
variable outcomes [24, 25]. There is an unmet need for a
predictable and reliable therapy.
The current study evaluates up to 1-year performance of
the Ar-HA biphasic scaffold implant in a goat model in
comparison with a defect in which blood clot extruding
from the bone marrow is allowed to form. The control
group is similar to a marrow stimulation technique [26],
which is widely clinically used. The 6-mm diameter osteo-
chondral defect cannot spontaneously repair in a goat
model [15] and thus is of critical size [13, 16]. Indeed, none
of group A animals had full cartilage and bone repair.
The goat cartilage repair model is frequently used to
study osteochondral grafting and meniscal repair [27, 28],
as the knee joints are large enough to create lesions similar
in size to those treated in human patients[17].
In contrast to the marrow stimulation induced by the
osteochondral defect creation that failed to produce high-
quality repair, Ar-HA implants induced high-quality repair
tissue formation with long-term durability, similar to pre-
vious shorter-term follow-up results [9].
Cartilage is devoid of nerve fibers, and pain generation
appears to be subchondral bone related, thus, replace-
ment of the subchondral bone could be advocated in
cartilage lesions as abnormal subchondral bone appears
to be related to osteoarthritis progression [29]. The ad-
vantage of the Ar-HA implant compared to superficial
cartilage treatment relates to reconstruction of the osteo-
chondral bone in an osteotransduction process [30]. A
concern with osteochondral replacement in chondral le-
sions might be inconsistent bone regeneration leading to
geode formation. In this study, the Ar-HA-based scaffold
proved to consistently support osseous and cartilaginous
tissue formation lending confidence to osteochondral re-
placement in full-thickness cartilage lesions.
The chondral phase of the implant stimulates forma-
tion of hyaline cartilage due to a composite of modified
AR with HA. HA is critical for the maintenance of the
physico-chemical characteristics of extracellular cartilage
matrix, with both chondrogenesis and chondro-protec-
tion effects [31]. HA bonded to a substrate exhibits a
size-dependent stimulation of chondrogenic differenti-
ation [32] and influences cell motility, cell differenti-
ation, and cell development. In previous studies [10], the
unique spatial orientation of the implant was recognized
to regenerate cartilage.The bone phase of the Ar-HA implant is an aragonite
derivative, an osteo-conductive and osteo-transductive
nanomaterial, reminiscent of human bone due to its 3D
structure and crystalline form of calcium carbonate
(CaCO3), together with macro- and micro-porosity and
pore interconnections [33, 34]. In addition, pore intercon-
nectives are optimal for the development of Haversian sys-
tems and the essential entry of blood vessels [35, 36].
An advantage of the current study is the multimodality
imaging assessment of the repair tissue. Ultrasound con-
firmed the superiority of the superficial repair tissue in
group B, while micro-CT results indicate that in group B
animals, the regenerated bone is similar in density to the
native bone, in stark contrast with the group A animals.
MRI confirmed the superior repair tissue formation of
group B animals. The articular degeneration mitigation
of the implant is evidenced by MRI findings (T2 map-
ping) of surrounding articular cartilage preservation in
the implanted group as opposed to cartilage degener-
ation in the control animals. This corroborates results
by Schinhan et al. [13] that such defects in the medial
tibiofemoral joint of the goat consistently induce osteo-
arthritic changes if left untreated. Mesenchymal cell injec-
tion into the knee has previously been shown to retard
osteoarthritis progression [37], however, this is the first
report that a cell-free scaffold can retard osteoarthritic
changes in the cartilage surrounding a focal defect.
The histological results in this study are closely related
to the MOCART scoring. Consistency of the repair ob-
tained with the scaffold implantation is attested by the
very small standard deviation in the treated group im-
aging and histological results.
A limitation of the study is the limited follow-up. A 1-
year follow-up time point is common in animals due to
their limited lifespan. However, human studies often re-
quire 2-year follow-up as a minimum.
A pre-requisite for extensive use of a novel osteochon-
dral implant is its safety. In the current study, no (SAE)
were observed in the Ar-HA group and one non-related
SAE occurred in a group A animal. After 6 and 12
months, no significant local inflammation was observed
in both groups, thus supporting the biocompatibility and
safety of this scaffold.
The Ar-HA scaffold led to restoration of the articular
surface without the need of exogenous cells. Clinical ap-
plication of this technique has to be tested in future
studies. The technique might allow simplification of the
osteochondral treatment algorithm. An off-the-shelf,
single-stage solution for the treatment of cartilage de-
fects is potentially of great importance.
Conclusions
This study assessed the long-term efficacy and safety of
the Ar-HA implant. The scaffold allowed full restoration
Kon et al. Journal of Orthopaedic Surgery and Research  (2015) 10:81 Page 16 of 17of both a high-quality cartilage as well as the subchondral
bone. The regenerated tissues appear to undergo further
maturation and remodeling from the 6- to the 12-month
follow-up. These results could support the postulate that
the Ar-HA scaffold is suitable for the repair of cartilage
and osteochondral lesions in humans [10].
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